janmacek
☆    

Czech Republic,
2016-05-11 15:09
(3301 d 04:47 ago)

Posting: # 16293
Views: 2,577
 

 Method validation for each species [Bioanalytics]

Post reply
Dear all,

we are planning validation of a bioanalytical method for the determination of a drug candidate in plasma. This method should be used for the analysis of samples from various species (rat, mouse, dog, etc.). The European Guideline states that full validation should be performed for each species and matrix concerned, while the FDA guideline states that partial validation is required for the change of species within matrix.

What is your experience with this topic? Is the approach really different in Europe and US?

With best regards,

Jan
 
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
49 visitors (0 registered, 49 guests [including 5 identified bots]).
Forum time: 19:56 CEST (Europe/Vienna)

An expert is someone who knows some of the worst mistakes
that can be made in his subject,
and how to avoid them.    Werner Heisenberg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5